Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Shelf-stable, ready-to-use therapeutic patches: Dip-and-deliver solutions for personalized wound care.

Bioengineering & translational medicine·2026
Same author

Optimizing C14120-based lipid nanoparticles for mRNA delivery: Editorial commentary.

Molecular therapy. Nucleic acids·2026
Same author

CORE: Cholesterol Altered Lipid Nanoparticles for Splenic Expression of mRNA Payloads.

Advanced healthcare materials·2026
Same author

Dual-band dual-circularly polarized and orbital angular momentum multiplexed reflectarray.

Optics express·2026
Same author

Characterizing the Impact of the Cell Cycle on mRNA Lipid Nanoparticles.

Journal of the American Chemical Society·2026
Same author

Non-viral gene delivery for non-small cell lung cancer.

Annals of translational medicine·2026

相关实验视频

Updated: May 23, 2025

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

22.7K

mRNA脂质纳米粒子的配方,表征和评估.

Yutian Ma1, Rachel VanKeulen-Miller2, Owen S Fenton3

  • 1Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Nature protocols
|March 12, 2025
PubMed
概括
此摘要是机器生成的。

本指南简化了信使RNA (mRNA) 脂质纳米颗粒 (LNP) 的配方,表征和评估. 它提供了一个统一的工作流程,以帮助研究人员更轻松地进入mRNA LNP领域.

更多相关视频

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

10.8K
Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
11:13

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate

Published on: May 9, 2019

8.7K

相关实验视频

Last Updated: May 23, 2025

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
09:41

Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform

Published on: February 25, 2021

22.7K
Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing
08:55

Testing the In Vitro and In Vivo Efficiency of mRNA-Lipid Nanoparticles Formulated by Microfluidic Mixing

Published on: January 20, 2023

10.8K
Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate
11:13

Enrichment of Native Lipoprotein Particles with microRNA and Subsequent Determination of Their Absolute/Relative microRNA Content and Their Cellular Transfer Rate

Published on: May 9, 2019

8.7K

科学领域:

  • 生物技术是生物技术.
  • 纳米医学是一种纳米医学.
  • 分子生物学分子生物学

背景情况:

  • 使者RNA (mRNA) 疗法具有显著的治疗潜力.
  • 复杂的制定和评估工作流程为进入mRNA脂质纳米粒子 (LNP) 领域的研究人员创造了障碍.

研究的目的:

  • 为 mRNA LNP 配方,表征和体外/体内评估提供简化,逐步的指南.
  • 降低科学家在学术界,工业界和临床环境中参与mRNA LNP研究的障碍.
  • 将制定,描述和评估整合到一个单一的,可访问的工作流中.

主要方法:

  • 制定mRNA LNP的详细协议.
  • 关键参数的表征:大小,PDI,泽塔潜力,mRNA度,封装效率和稳定性.
  • 在体外评估:蛋白质表达,细胞吸收和内体细胞逃逸.
  • 在体内评估:蛋白质表达,生物分布和耐受性研究.

主要成果:

  • 介绍了mRNA LNP生产和评估的综合性协议.
  • 该指南涵盖了配方,表征和体外和体外评估.
  • 该工作流被设计为适用于各种mRNA LNP配方.

结论:

  • 这一综合协议通过简化复杂的程序,方便进入mRNA LNP研究.
  • 该工作流的传播旨在促进在mRNA LNP开发中的创新和合作.
  • 最终的目标是加速基于mRNA的治疗方法的翻译进步.